Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deontological Guilt Differentially Affects Moral Behaviour in Participants With and Without Obsessive-Compulsive Disorder (OCD).

Clinical psychology & psychotherapy·2026
Same author

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

European review for medical and pharmacological sciences·2025
Same author

Pituitary tumor-transforming gene 1 and endocrine cancers: an up-to-date review through history, current insights and future perspectives.

Endocrine-related cancer·2025
Same author

Development and Characterization of a 13-Plex Binding Assay to Detect <i>Shigella</i> Antibodies in Human Samples.

Open forum infectious diseases·2024
Same author

Workplace violence in radiology: results of a systematic review.

Occupational medicine (Oxford, England)·2023
Same author

Combined evaluation of prolactin-induced peptide (PIP) and extracellular signal-regulated kinase (ERK) as new sperm biomarkers of FSH treatment efficacy in normogonadotropic idiopathic infertile men.

Journal of endocrinological investigation·2023
Same journal

RNA Modifications as Drug Targets: Unlocking the Therapeutic Potential of the Epitranscriptome.

Current genomics·2026
Same journal

AgriBioNER: A Named Entity Recognition Tool for Identification of ncRNA and Diseases in Agricultural Literature.

Current genomics·2026
Same journal

Understanding the Evolutionary Adaptations and the Associated Functional Dynamics of Diatom <i>Cyclotella Cryptica</i>: A Chloroplast Genome-wide Comparative Study.

Current genomics·2026
Same journal

The Role of Collagen Genetic Variability in Degenerative Disc Disease and Related Conditions.

Current genomics·2026
Same journal

Genomics-Driven Immunotherapy: Advancing Cancer Treatment through Personalized Approaches.

Current genomics·2026
Same journal

Innovative Applications and Challenges of Isothermal Amplification Technology in miRNA Detection.

Current genomics·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

MDM4 (MDMX) and its Transcript Variants.

F Mancini1, G Di Conza, F Moretti

  • 1National Council of Research, Institute of Neurobiology and Molecular Medicine, Roma.

Current Genomics
|September 2, 2009
PubMed
Summary
This summary is machine-generated.

MDM4 (MDM family member 4) splicing variants fine-tune wild-type protein function in normal cells but can promote oncogenesis in tumors. This review details MDM4 variants, their structures, and interactions, comparing them to MDM2 variants.

Keywords:
MDM2.MDM4MDM4-211MDM4-Sp53transcript variants

More Related Videos

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

CD Spectroscopy to Study DNA-Protein Interactions
06:48

CD Spectroscopy to Study DNA-Protein Interactions

Published on: February 10, 2022

Related Experiment Videos

Last Updated: Jun 20, 2026

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

CD Spectroscopy to Study DNA-Protein Interactions
06:48

CD Spectroscopy to Study DNA-Protein Interactions

Published on: February 10, 2022

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • MDM family proteins regulate the oncosuppressor p53, with gene alterations frequently observed in human tumors.
  • MDM4, a member of the MDM family, is encoded by a gene on chromosome 1 and exists as a full-length protein and various transcript variants.
  • These MDM4 variants arise from canonical and aberrant splicing, with some found in normal tissues and others exclusively in tumors.

Purpose of the Study:

  • To review all described MDM4 splicing forms and their regulatory roles on wild-type MDM4 function in both normal and tumor cells.
  • To present the structure of full-length MDM4 protein, its interacting partners, and compare the structures of MDM4 variants to the full-length protein.
  • To discuss the parallels between MDM4 and MDM2 variants in cancer biology.

Main Methods:

  • Literature review of studies describing MDM4 splicing variants.
  • Analysis of protein structure and interactions of full-length MDM4.
  • Comparative analysis of MDM4 and MDM2 variants.

Main Results:

  • MDM4 variants are generated through splicing, including aberrant events, and exhibit differential expression in normal versus tumor tissues.
  • Some MDM4 variants modulate the function of the full-length protein in normal cells, while others possess oncogenic properties in tumor cells.
  • The review provides a comprehensive overview of MDM4 variant structures, interactions, and functional implications.

Conclusions:

  • MDM4 splicing variants play a significant role in regulating p53 pathway activity, impacting both normal cellular functions and tumor development.
  • Understanding MDM4 variants is crucial for comprehending cancer mechanisms and potentially developing targeted therapies.
  • The comparison with MDM2 variants highlights conserved and distinct roles of MDM family members in cancer.